Investor Presentaiton slide image

Investor Presentaiton

IDH Development Story Over 35 years of industry experience, complemented by strategic expansion to develop a strong market position across products and geographies Establishment Al Borg was IDH of MK Lab founded established by Abraaj Expansion of IDH Expansion of product offering Building infrastructure and scale Creating a leading platform Integration and further expansion A year of transformation Steadiness post-float 1979 1990 2008 2009 2010 2011 2012 2013-14 2015 2017 ⚫ Dr. Moamena Kamel, Professor of Immunology at Cairo University, founds the MK Lab which later merges with Al Mokhtabar in 2004 • Founded by a group of four doctors, Al Borg is the first medical laboratory in Egypt to have an efficient hub, spoke and spike model ⚫ Abraaj acquires 76.8% of Al Borg to establish IDH Caymans • Branches(1): 127 . Acquisition of . 99.9% stake in Molecular Diagnostics Centre ⚫ Branches(1) 154 Acquisition of 54.98% stake in Medical Genetics Centre • Increase of stake in Al Borg to 80% post its delisting • Branches(1): 195 • Penetration in Sudan and Jordan comes with acquisition of Ultralab and Biolab, Acquisition of 99.9% of Al Mokhtabar (Al Borg's biggest competitor) • Increase of stake in Al Borg to 99.3% respectively • Branches(1): Branches(1): 210 214 Establishes the largest automated lab in Egypt • Diversifies into adjacent medical services • Branches(2): 262 (2013); 288 (2014) • Standard listing on the London Stock Exchange (LSE). Market cap. of USD 667.5 mn • Initial operations at Megalab begin. • 28 new branches added • Delivering strong top- and bottom- line growth despite impact of the November 2016 float of the EGP • Entered the Nigerian market with the acquisition of Eagle Eye Echo- Scan Limited ("Echo- Scan") through a JV with Man Capital IDH has built a scalable platform that is positioned for further strong growth Note: Source: (1) Branches refer to core operations of Al Borg and Al Mokhtabar in Egypt (2) Branches refer to the IDH group Company data 5 INTEGRATED DIAGNOSTICS HOLDINGS
View entire presentation